Stroke, Vol 21, 138-140, Copyright © 1990 by American Heart Association
DM Rosenbaum, JC Grotta, LC Pettigrew, P Ostrow, R Strong, H Rhoades, CM Picone and AT Grotta
Presynaptic release of glutamate into the extracellular compartment and
activation of receptor-operated calcium channels may contribute to ischemic
neuronal damage. We evaluated the effect of baclofen, a selective inhibitor
of presynaptic glutamate release, on mortality, working memory, and light
microscopic hippocampal and cortical damage in the four-vessel occlusion
model of cerebral ischemia using 64 male Wistar rats. Baclofen (10 mg/kg
i.p.) given 1 hour before and 30-60 minutes after 20 minutes of global
ischemia did not lessen mortality, prevent ischemic cellular damage, or
significantly improve working memory compared with no treatment. We
conclude that preischemic and postischemic administration of baclofen does
not protect neurons from ischemic injury.
ARTICLES
Baclofen does not protect against cerebral ischemia in rats
Department of Neurology, University of Texas Health Science Center, Houston 77030.
This article has been cited by other articles:
![]() |
C. Costa, G. Leone, E. Saulle, F. Pisani, G. Bernardi, and P. Calabresi Coactivation of GABAA and GABAB Receptor Results in Neuroprotection During In Vitro Ischemia Stroke, February 1, 2004; 35(2): 596 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Madden, W. Clark, and N. Lessov Failure of Ischemic Neuroprotection by Potentiators of Gamma-aminobutyric Acid Clin. Med. Res., April 1, 2003; 1(2): 119 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Ginsberg Review : Neuroprotection in Brain Ischemia: An Update (Part II Neuroscientist, May 1, 1995; 1(3): 164 - 175. [Abstract] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |